Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Yasumasa, Higuchi, Makoto, Zhang, Bin, Huang, Shu-Ming, Iwata, Nobuhisa, Saido, Takaomi C., Maeda, Jun, Suhara, Tetsuya +2 more·2007·Neuron

Cited by (1,029)

Items 401–500 of 1,029

  1. Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease
    Cao, Qing, Wang, Wei, Williams, Jamal B., Yang, Fengwei, Wang, Zi-Jun, Yan, Zhen · 2020 · Science Advances
  2. Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
    Yao, Hailan, Coppola, Kyle, Schweig, Jonas Elias, Crawford, Fiona, Mullan, Michael, Paris, Daniel · 2019 · Frontiers in Cellular Neuroscience
  3. Synapse elimination during development and disease: immune molecules take centre stage
    Dorothy P. Schafer, Beth Stevens · 2010 · Biochemical Society Transactions
  4. Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
    Castellani, Rudy J., Perry, George · 2019 · Journal of Alzheimer’s Disease
  5. TGF-β1 signalling in Alzheimer’s pathology and cytoskeletal reorganization: a specialized Tau perspective
    Mahima Kapoor, Subashchandrabose Chinnathambi · 2023 · Journal of Neuroinflammation
  6. Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease
    Stephanie L. Fowler, Tiana S. Behr, Emir Turkes, Darragh Patrick O'Brien, Paula Maglio Cauhy, Isadora Rawlinson, Marisa J. Edmonds, Martha S. Foiani, Ari W. Schaler, Gerard Crowley et al. · 2024 · Nature Neuroscience
  7. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits
    Andrew M. Ward, Elizabeth C. Mormino, Willem Huijbers, Aaron P. Schultz, Trey Hedden, Reisa Anne Sperling · 2014 · Neurobiology of Aging
  8. Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease
    Watts, Joel C., Giles, Kurt, Grillo, Sunny K., Lemus, Azucena, DeArmond, Stephen J., Prusiner, Stanley B. · 2011 · Proceedings of the National Academy of Sciences
  9. Application of Iron Oxide Nanoparticles in the Diagnosis and Treatment of Neurodegenerative Diseases With Emphasis on Alzheimer’s Disease
    Shen Luo, Chi Ma, Mingqin Zhu, Wei-Na Ju, Yang Yu, Xu Wang · 2020 · Frontiers in Cellular Neuroscience
  10. An Engulfment Assay: A Protocol to Assess Interactions Between CNS Phagocytes and Neurons
    Schafer, Dorothy P., Lehrman, Emily K., Heller, Christopher T., Stevens, Beth · 2014 · Journal of Visualized Experiments
  11. Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
    Mashoque Ahmad Rather, Andleeb Khan, Saeed Alshahrani, Hina Rashid, Marwa M. Qadri, Summya Rashid, Rana M. Alsaffar, Mohammad Amjad Kamal, Muneeb U. Rehman · 2021 · Mediators of Inflammation
  12. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy
    Ljungberg, M. Cecilia, Ali, Yousuf O., Zhu, Jie, Wu, Chia-Shan, Oka, Kazuhiro, Zhai, R. Grace, Lu, Hui-Chen · 2012 · Human Molecular Genetics
  13. Molecular Chaperones: A Double-Edged Sword in Neurodegenerative Diseases
    Jessica Tittelmeier, Eliana Nachman, Carmen I. Nussbaum-Krammer · 2020 · Frontiers in Aging Neuroscience
  14. Characteristics of TBS-Extractable Hyperphosphorylated Tau Species: Aggregation Intermediates in rTg4510 Mouse Brain
    Naruhiko Sahara, Michael A. Deture, Yan Ren, Abdul-Shukkur Ebrahim, Dongcheul Kang, Joshua A. Knight, Christiane Volbracht, Jan T. Pedersen, Dennis W. Dickson, Shu-Hui C. Yen et al. · 2012 · Journal of Alzheimer s Disease
  15. Role of Microglial Cells in Alzheimer’s Disease Tau Propagation
    Ena Španić, Lea Langer Horvat, Patrick R. Hof, Goran Šimić · 2019 · Frontiers in Aging Neuroscience
  16. TFEB–vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy
    Baiping Wang, Heidi Martini‐Stoica, Chuangye Qi, Tzu‐Chiao Lu, Shuo Wang, Wen Xiong, Yanyan Qi, Yin Xu, Marco Sardiello, Hongjie Li et al. · 2023 · Nature Neuroscience
  17. Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
    Garwood, Claire J., Cooper, Jonathan D., Hanger, Diane P., Noble, Wendy · 2010 · Frontiers in Psychiatry
  18. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma
    Marius Chiasseu, Jorge L. Cueva Vargas, Laurie Destroismaisons, Christine Vande Velde, Nicole M. Leclerc, Adriana Di Polo · 2016 · Journal of Neuroscience
  19. Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
    Olivia Sheppard, Michael P. Coleman · 2020 · Exon Publications eBooks
  20. Dendritic Spine Instability Leads to Progressive Neocortical Spine Loss in a Mouse Model of Huntington's Disease
    Murmu, R. P., Li, W., Holtmaat, A., Li, J.-Y. · 2013 · Journal of Neuroscience
  21. Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration
    Maria E. Figueiredo‐Pereira, Patricia Rockwell, Thomas Schmidt‐Glenewinkel, Peter A. Serrano · 2015 · Frontiers in Molecular Neuroscience
  22. Tau physiology and pathomechanisms in frontotemporal lobar degeneration
    Bodea, Liviu‐Gabriel, Eckert, Anne, Ittner, Lars Matthias, Piguet, Olivier, Götz, Jürgen · 2016 · Journal of Neurochemistry
  23. The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
    Barbara Mroczko, Magdalena Groblewska, Ala Litman‐Zawadzka · 2019 · International Journal of Molecular Sciences
  24. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
    Aurélie Joly‐Amado, Jordan Hunter, Zainuddin Quadri, Frank Zamudio, Patricia Rocha-Rangel, Deanna Chan, Anisha Kesarwani, Kevin R. Nash, Daniel C. Lee, David Morgan et al. · 2020 · Frontiers in Immunology
  25. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells
    Ojala, Johanna O., Sutinen, Elina M., Salminen, Antero, Pirttilä, Tuula · 2008 · Journal of Neuroimmunology
  26. Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis
    Zhao, Yingjun, Tseng, I-Chu, Heyser, Charles J., Rockenstein, Edward, Mante, Michael, Adame, Anthony, Zheng, Qiuyang, Huang, Timothy, Wang, Xin, Arslan, Pharhad E. et al. · 2015 · Neuron
  27. Microglial Activation in Alzheimers Disease
    Johannes C. M. Schlachetzki, Michael Hüll · 2009 · Current Alzheimer Research
  28. TIA1 regulates the generation and response to toxic tau oligomers
    Lulu Jiang, Peter E.A. Ash, Brandon F. Maziuk, Heather I. Ballance, Samantha Boudeau, Ali Al Abdullatif, Marcello Orlando, Leonard Petrucelli, Tsuneya Ikezu, Benjamin L. Wolozin · 2018 · Acta Neuropathologica
  29. A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice
    Qian Guo, Shuting Xu, Peng Yang, Pengzhen Wang, Shuai Lü, Dongyu Sheng, Kang Qian, Jinxu Cao, Wei Lü, Qizhi Zhang · 2020 · Journal of Controlled Release
  30. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
    Trzeciakiewicz, Hanna, Ajit, Deepa, Tseng, Jui-Heng, Chen, Youjun, Ajit, Aditi, Tabassum, Zarin, Lobrovich, Rebecca, Peterson, Claire, Riddick, Natallia V., Itano, Michelle S. et al. · 2020 · Nature Communications
  31. Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
    Takashi Amemori, Pavla Jendelová, Jiří Růžička, Lucia Machová Urdzíková, Eva Syková · 2015 · International Journal of Molecular Sciences
  32. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice
    Odochi Ohia-Nwoko, Saghi Montazari, Yuen‐Sum Lau, Jason L. Eriksen · 2014 · Molecular Neurodegeneration
  33. Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology
    Makoto Higuchi, Nobuhisa Iwata, Yukio Matsuba, Jiro Takano, Takahiro Suemoto, Jun Maeda, Bin Ji, Maiko Ono, Matthias Staufenbiel, Tetsuya Suhara et al. · 2011 · The FASEB Journal
  34. Multicolor time-stamp reveals the dynamics and toxicity of amyloid deposition
    Carlo Condello, Aaron J. Schain, Jaime Grutzendler · 2011 · Scientific Reports
  35. Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
    Yanamandra, Kiran, Patel, Tirth K., Jiang, Hong, Schindler, Suzanne, Ulrich, Jason D., Boxer, Adam L., Miller, Bruce L., Kerwin, Diana R., Gallardo, Gilbert, Stewart, Floy et al. · 2017 · Science Translational Medicine
  36. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia
    Ana M. García-Cabrero, Rosa Guerrero, Beatriz G. Giráldez, Marı́a Llorens-Martı́n, Jesús Ávila, José María Serratosa, Marina P. Sánchez · 2013 · Neurobiology of Disease
  37. Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
    Yan Zhu, Guanxia Zhan, Polina Fenik, M Brandes, Patrick Bell, Noëlle François, Katherine Shulman, Sigrid Carlen Veasey · 2018 · Journal of Neuroscience
  38. Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
    Kathryn A Conn, Emily M. Borsom, Emily K. Cope · 2024 · Gut Microbes
  39. Alpha7 nicotinic acetylcholine receptor: A link between inflammation and neurodegeneration
    Concepcion Conejero‐Goldberg, Peter Davies, Luis Ulloa · 2007 · Neuroscience & Biobehavioral Reviews
  40. Reductions in Amyloid-β-Derived Neuroinflammation, with Minocycline, Restore Cognition but do not Significantly Affect Tau Hyperphosphorylation
    Anna I. Parachikova, Vitaly Vasilevko, David H. Cribbs, Frank M. LaFerla, Kim N. Green · 2010 · Journal of Alzheimer s Disease
  41. FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice
    Takehiro Nakagaki, Katsuya Satoh, Daisuke Ishibashi, Takayuki Fuse, Kazunori Sano, Yuji O. Kamatari, Kazuo Kuwata, Kazuto Shigematsu, Yoshifumi Iwamaru, Takato Takenouchi et al. · 2013 · Autophagy
  42. Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice
    Mala V. Rao, Mary Kate McBrayer, J. Campbell, Ashok Kumar, Ali Talib Hashim, Henry W. Sershen, Philip H. Stavrides, Masuo Ohno, Mike Hutton, Ralph A. Nixon · 2014 · Journal of Neuroscience
  43. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration
    Sahara, N., Maeda, S., Takashima, A. · 2008 · Current Alzheimer Research
  44. Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer’s and other neurodegenerative diseases
    Golde, Todd E, Miller, Victor M · 2009 · Alzheimer's Research & Therapy
  45. Extracellular low‐n oligomers of tau cause selective synaptotoxicity without affecting cell viability
    Senthilvelrajan Kaniyappan, RamReddy Chandupatla, Eva‐Maria Mandelkow, Eckhard Mandelkow · 2017 · Alzheimer s & Dementia
  46. Hippocampal tauopathy in tau transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission
    Ann Van der Jeugd, Tariq Ahmed, Sylvie Burnouf, Karim Bélarbi, Malika Hamdame, Marie‐Eve Grosjean, Sandrine Humez, Detlef Balschun, David L Blum, Luc Buée et al. · 2010 · Neurobiology of Learning and Memory
  47. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy
    Norbert Žilka, Zuzana Stožická, Andrej Kováč, Emil Pilipcinec, Ondrej Bugos, Michal Novák · 2009 · Journal of Neuroimmunology
  48. Mouse models of frontotemporal dementia
    Erik D. Roberson · 2012 · Annals of Neurology
  49. Early behavioural markers of disease in P301S tau transgenic mice
    María Luisa Scattoni, Laura Gasparini, Enrico Alleva, Michel Goedert, Gemma Calamandrei, Maria Grazia Spillantini · 2009 · Behavioural Brain Research
  50. Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue
    Sarah K. Kaufman, Talitha L. Thomas, Kelly Del Tredici, Heiko Braak, Marc I. Diamond · 2017 · Acta Neuropathologica Communications
  51. Inflammation in transgenic mouse models of neurodegenerative disorders
    Schwab, Claudia, Klegeris, Andis, McGeer, Patrick. L. · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  52. MEF2 is a Key Regulator of Cognitive Potential and Confers Resilience to Neurodegeneration
    Barker, Scarlett J., Raju, Ravikiran M., Milman, Noah E.P., Wang, Jun, Davila-Velderrain, Jose, Gunter-Rahman, Fatima, Parro, Cameron C., Bozzelli, P. Lorenzo, Abdurrob, Fatema, Abdelaal, Karim et al. · 2021 · Science Translational Medicine
  53. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
    Weijun Ou, Joshua Yang, Juste Simanauskaite, Matthew K. Choi, Demi M. Castellanos, Rudy Chang, Jiahong Sun, Nataraj Jagadeesan, Karen D. Parfitt, David H. Cribbs et al. · 2021 · Journal of Neuroinflammation
  54. TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
    Z. Zhang, Dilshan S. Harischandra, Ruifang Wang, Shivani Ghaisas, Janet Yinqing Zhao, Thomas P. McMonagle, Guixin Zhu, Kenzo D. Lacuarta, Jianing Song, John Q. Trojanowski et al. · 2023 · Science
  55. A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
    Anna G. Flury, Leen Aljayousi, Hye-Jin Park, Mohammadparsa Khakpour, Jack Mechler, Siaresh Aziz, Jackson D. McGrath, Pragney Deme, Colby Sandberg, Fernando Gonzàlez Ibáñez et al. · 2024 · Neuron
  56. The Role of Tau in Neurodegenerative Diseases and Its Potential as a Therapeutic Target
    Michael S. Wolfe · 2012 · Scientifica
  57. Triggering Receptor Expressed on Myeloid Cells 2 Deficiency Alters Acute Macrophage Distribution and Improves Recovery after Traumatic Brain Injury
    Maha Saber, Olga N. Kokiko‐Cochran, Shweta S. Puntambekar, Justin Durla Lathia, Bruce T. Lamb · 2016 · Journal of Neurotrauma
  58. Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
    Jennifer L. Furman, Brandon B. Holmes, Marc I. Diamond · 2015 · Journal of Visualized Experiments
  59. Tau-mediated synaptic damage in Alzheimer’s disease
    Santosh Jadhav, Veronika Cubinkova, Ivana Zimova, Veronika Brezováková, Aladár Maďari, Viera Cigánková, Norbert Žilka · 2015 · Translational Neuroscience
  60. Characterization of tau oligomeric seeds in progressive supranuclear palsy
    Julia E. Gerson, Urmi Sengupta, Cristian A. Lasagna‐Reeves, Marcos Jair Guerrero‐Munoz, Juan Carlos Troncoso, Rakez Kayed · 2014 · Acta Neuropathologica Communications
  61. Potential benefits of mindfulness-based interventions in mild cognitive impairment and Alzheimer’s disease: an interdisciplinary perspective.
    Larouche, Eddy, Hudon, Carol, Goulet, Sonia · 2015 · Behavioural Brain Research
  62. Amyloid‐β impairs the phagocytosis of dystrophic synapses by astrocytes in Alzheimer's disease
    Sanchez‐Mico, Maria V., Jimenez, Sebastian, Gomez‐Arboledas, Angela, Muñoz‐Castro, Clara, Romero‐Molina, Carmen, Navarro, Victoria, Sanchez‐Mejias, Elisabeth, Nuñez‐Diaz, Cristina, Sanchez‐Varo, Raquel, Galea, Elena et al. · 2021 · Glia
  63. Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons
    Patricia Rodriguez‐Rodriguez, Anna Matton, Paula Merino‐Serrais, Cristina Parrado‐Fernández, Alberto Rábano, Bengt G. Winblad, Jesús Ávila, Isidró Ferrer, Ángel Cedazo-Mı́nguez · 2017 · Brain
  64. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies
    Gibbons, Garrett S, Banks, Rachel A, Kim, Bumjin, Changolkar, Lakshmi, Riddle, Dawn M, Leight, Susan N, Irwin, David J, Trojanowski, John Q, Lee, Virginia M Y · 2018 · Journal of Neuropathology & Experimental Neurology
  65. Small Molecule p75NTR Ligands Reduce Pathological Phosphorylation and Misfolding of Tau, Inflammatory Changes, Cholinergic Degeneration, and Cognitive Deficits in AβPPL/S Transgenic Mice
    Thuy‐Vi V. Nguyen, Lin Shen, Lilith Vander Griend, Lisa N. Quach, Nadia P. Belichenko, Nay Lui Saw, Tao Yang, Mehrdad Shamloo, Tony Wyss‐Coray, Stephen M. Massa et al. · 2014 · Journal of Alzheimer s Disease
  66. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics
    Hanna Rosenmann, Nikolaos Grigoriadis, Hila Eldar-Levy, Avi Avital, Lea Rozenstein‐Tsalkovich, Olga Touloumi, Leah Behar, Tamir Ben‐Hur, Yosefa Avraham, Eliot Berry et al. · 2008 · Experimental Neurology
  67. Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease
    Rebecca P. Haberman, Audrey Branch, Michela Gallagher · 2017 · Neurotherapeutics
  68. Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer’s disease after 2 years of survival
    Lidija Radenović, Marija Nenadić, Marzena Ułamek-Kozioł, Sławomir Januszewski, Stanisław Jerzy Czuczwar, Pavle R. Anđjus, Ryszard M. Pluta · 2020 · Aging
  69. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease
    Camila Calfío, Andrea González, Sandeep Kumar Singh, Leonel E. Rojo, Ricardo Benjamin Maccioni · 2020 · Journal of Alzheimer s Disease
  70. Chronic exercise ameliorates the neuroinflammation in mice carrying NSE/htau23
    Yea‐Hyun Leem, Young-Ik Lee, Hee-Jeong Son, Sangho Lee · 2011 · Biochemical and Biophysical Research Communications
  71. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease
    Elyse Rosa, Sujeivan Mahendram, Yazi Diana Ke, Lars Matthias Ittner, Stephen D. Ginsberg, Margaret L. Fahnestock · 2016 · Neurobiology of Aging
  72. The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy
    Chengcheng Zhang, Ang Xing, Meng‐Shan Tan, Lan Tan, Jin‐Tai Yu · 2015 · Molecular Neurobiology
  73. p73 Regulates Neurodegeneration and Phospho-Tau Accumulation during Aging and Alzheimer's Disease
    Monica K. Wetzel, Sibel Naska, Christine L. Laliberté, Vladimir V. Rymar, Masashi Fujitani, Jeffrey Biernaskie, Christy J. Cole, Jason P. Lerch, Shoshana Spring, Szu‐Han Wang et al. · 2008 · Neuron
  74. Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies
    Kevin Lou, Yuemang Yao, Adam T. Hoye, Michael J. James, Anne‐Sophie Cornec, Edward G. Hyde, Bryant C. Gay, Virginia M.‐Y. Lee, John Q. Trojanowski, Amos B. Smith et al. · 2014 · Journal of Medicinal Chemistry
  75. Infectious origin of Alzheimer’s disease: Amyloid beta as a component of brain antimicrobial immunity
    Vojtechova, Iveta, Machacek, Tomas, Kristofikova, Zdenka, Stuchlik, Ales, Petrasek, Tomas · 2022 · PLOS Pathogens
  76. Phosphorylated Tau: Toxic, Protective, or None of the Above
    Rudy J. Castellani, Akihiko Nunomura, Hyoung‐gon Lee, George L. Perry, Mark A. Smith · 2008 · Journal of Alzheimer s Disease
  77. Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset
    Juan D. Rodríguez-Callejas, Eberhard Fuchs, Claudia Perez‐Cruz · 2016 · Frontiers in Aging Neuroscience
  78. Loss of tau rescues inflammation-mediated neurodegeneration
    Maphis, Nicole, Xu, Guixiang, Kokiko-Cochran, Olga N., Cardona, Astrid E., Ransohoff, Richard M., Lamb, Bruce T., Bhaskar, Kiran · 2015 · Frontiers in Neuroscience
  79. Decreased lipidated ApoE‐receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
    Guo, Jing L., Braun, Dylan, Fitzgerald, Gabriel A., Hsieh, Yun-Ting, Rougé, Lionel, Litvinchuk, Alexandra, Steffek, Micah, Propson, Nicholas E., Heffner, Catherine M., Discenza, Claire et al. · 2025 · Cell
  80. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
    Wang, Hong, Li, Yupeng, Ryder, John W., Hole, Justin T., Ebert, Philip J., Airey, David C., Qian, Hui-Rong, Logsdon, Benjamin, Fisher, Alice, Ahmed, Zeshan et al. · 2018 · Molecular Neurodegeneration
  81. Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model
    Litvinchuk, Alexandra, Huynh, Tien‐Phat V., Shi, Yang, Jackson, Rosemary J., Finn, Mary B., Manis, Melissa, Francis, Caroline M., Tran, Ainsley C., Sullivan, Patrick M., Ulrich, Jason D. et al. · 2021 · Annals of Neurology
  82. An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology
    Patrick W. Sheehan, Collin J. Nadarajah, Michael F. Kanan, Jessica N. Patterson, Brenna C. Novotny, Jennifer H. Lawrence, Melvin W. King, Logan Brase, Casey E. Inman, Carla M. Yuede et al. · 2023 · Neuron
  83. Microglia display modest phagocytic capacity for extracellular tau oligomers
    Majerova, Petra, Zilkova, Monika, Kazmerova, Zuzana, Kovac, Andrej, Paholikova, Kristina, Kovacech, Branislav, Zilka, Norbert, Novak, Michal · 2014 · Journal of Neuroinflammation
  84. Repositioning Microtubule Stabilizing Drugs for Brain Disorders
    Artemis Varidaki, Ye Hong, Eleanor T. Coffey · 2018 · Frontiers in Cellular Neuroscience
  85. Social isolation induces neuroinflammation and microglia overactivation, while dihydromyricetin prevents and improves them
    Alzahra J. Al Omran, Amy S. Shao, Saki Watanabe, Zeyu Zhang, Jifeng Zhang, Xue Chen, Junji Watanabe, Daryl L. Davies, Xuesi M. Shao, Jing Liang · 2022 · Journal of Neuroinflammation
  86. Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
    Tian, Huilai, Davidowitz, Eliot, Lopez, Patricia, Emadi, Sharareh, Moe, James, Sierks, Michael · 2013 · International Journal of Cell Biology
  87. Stimulation of TLR4 Attenuates Alzheimer’s Disease–Related Symptoms and Pathology in Tau-Transgenic Mice
    Qin, Yiren, Liu, Yang, Hao, Wenlin, Decker, Yann, Tomic, Inge, Menger, Michael D, Liu, Chunfeng, Fassbender, Klaus · 2016 · The Journal of Immunology
  88. Tau at the interface between neurodegeneration and neuroinflammation
    Didonna, Alessandro · 2020 · Genes & Immunity
  89. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
    Piao Luo, Shi-Feng Chu, Zhao Zhang, Cong-yuan Xia, Nai-Hong Chen · 2019 · Brain Research Bulletin
  90. Crosstalk between Oxidative Stress and Tauopathy
    Md. Mamunul Haque, Dhiraj P. Murale, Yun Kyung Kim, Jun‐Seok Lee · 2019 · International Journal of Molecular Sciences
  91. Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
    Dutta, Debashis, Jana, Malabendu, Paidi, Ramesh Kumar, Majumder, Moumita, Raha, Sumita, Dasarathy, Sridevi, Pahan, Kalipada · 2023 · Journal of Clinical Investigation
  92. Presence of Reactive Microglia and Neuroinflammatory Mediators in a Case of Frontotemporal Dementia with P301S Mutation
    Arianna Bellucci, Orso Bugiani, Bernardino Francesco Ghetti, Maria Grazia Spillantini · 2011 · Neurodegenerative Diseases
  93. LSD1 protects against hippocampal and cortical neurodegeneration
    Michael A. Christopher, Dexter A. Myrick, Benjamin G. Barwick, Amanda Engstrom, Kirsten A. Porter‐Stransky, Jeremy M. Boss, David Weinshenker, Allan I. Levey, David J. Katz · 2017 · Nature Communications
  94. Microglial REV-ERBα regulates inflammation and lipid droplet formation to drive tauopathy in male mice
    Jiyeon Lee, Julie M. Dimitry, Jong Hee Song, Minsoo Son, Patrick W. Sheehan, Melvin W. King, G. Travis Tabor, Young Ah Goo, Mitchell A. Lazar, Leonard Petrucelli et al. · 2023 · Nature Communications
  95. Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
    Kumaran, Ravindran, Cookson, Mark R. · 2015 · Human Molecular Genetics
  96. Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer's Disease
    Lauren G. Friedman, Yasir H. Qureshi, Wai Haung Yu · 2014 · Neurotherapeutics
  97. A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Jacob A. Sloane, Daina Blitz, Zachary R. Margolin, Timothy K. Vartanian · 2009 · NeuroMolecular Medicine
  98. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
    Jens Wagner, Sybille Krauß, Song Shi, Sergey Ryazanov, Julia Steffen, Carolin Miklitz, Andrei Leonov, Alexander Kleinknecht, Bettina Göricke, Jochen Hans Weishaupt et al. · 2015 · Acta Neuropathologica
  99. Tau Aggregates: Toxic, Inert, or Protective Species?
    Alexis Bretteville, Emmanuel Planel · 2008 · Journal of Alzheimer s Disease
  100. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic
    Simon Dujardin, Morvane Colin, Luc Buée · 2014 · Neuropathology and Applied Neurobiology